13198 related articles for article (PubMed ID: 10338337)
1. Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma.
Fukuda H; Honda C; Wadabayashi N; Kobayashi T; Yoshino K; Hiratsuka J; Takahashi J; Akaizawa T; Abe Y; Ichihashi M; Mishima Y
Melanoma Res; 1999 Feb; 9(1):75-83. PubMed ID: 10338337
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
[TBL] [Abstract][Full Text] [Related]
3. Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of 10B-boronophenylalanine (10B-BPA) used in boron neutron capture therapy.
Pitois A; de las Heras LA; Zampolli A; Menichetti L; Carlos R; Lazzerini G; Cionini L; Salvatori PA; Betti M
Anal Bioanal Chem; 2006 Feb; 384(3):751-60. PubMed ID: 16372182
[TBL] [Abstract][Full Text] [Related]
4. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
Joel DD; Coderre JA; Micca PL; Nawrocky MM
J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of
Fukuda H; Hiratsuka J
Appl Radiat Isot; 2020 Dec; 166():109308. PubMed ID: 32823081
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
[TBL] [Abstract][Full Text] [Related]
8. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
[TBL] [Abstract][Full Text] [Related]
9. Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001).
Wittig A; Malago M; Collette L; Huiskamp R; Bührmann S; Nievaart V; Kaiser GM; Jöckel KH; Schmid KW; Ortmann U; Sauerwein WA
Int J Cancer; 2008 Mar; 122(5):1164-71. PubMed ID: 17985341
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.
Fukuda H; Hiratsuka J; Honda C; Kobayashi T; Yoshino K; Karashima H; Takahashi J; Abe Y; Kanda K; Ichihashi M
Radiat Res; 1994 Jun; 138(3):435-42. PubMed ID: 8184019
[TBL] [Abstract][Full Text] [Related]
13. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
Morris GM; Coderre JA; Micca PL; Fisher CD; Capala J; Hopewell JW
Br J Cancer; 1997; 76(12):1623-9. PubMed ID: 9413952
[TBL] [Abstract][Full Text] [Related]
15. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
Barth RF; Yang W; Bartus RT; Rotaru JH; Ferketich AK; Moeschberger ML; Nawrocky MM; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):858-68. PubMed ID: 11849812
[TBL] [Abstract][Full Text] [Related]
16. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
[TBL] [Abstract][Full Text] [Related]
17. [Neutron capture therapy for cancer].
Fukuda H; Ichihashi M; Mishima Y
Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1833-41. PubMed ID: 9717809
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
20. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
